Amyotrophic Lateral Sclerosis (ALS)

  • Matteo Cecchi et al. Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):371-5.
  • Iłzecka J et al. Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids. 2003 Jul;25(1):69-73.
  • Matteo Cecchi et al. Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):371-5.
  • Sana Latif , Young-Sook Kang et al.  Differences of Transport Activity of Arginine and Regulation on Neuronal Nitric Oxide Synthase and Oxidative Stress in Amyotrophic Lateral Sclerosis Model Cell Lines. Cells. 2021 Dec 16;10(12):3554.
  • Blin et al. Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application. Rev Neurol (Paris). 1991;147(5):392-4.
  • J D Rothstein 1, L J Martin, R W Kuncl. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992 May 28;326(22):1464-8.
  • A Plaitakis 1, E Constantakakis, J Smith. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol. 1988 Sep;24(3):446-9.
  • T L Perry et al. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol. 1990 Jul;28(1):12-7.
  • Lee A.  A double-blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand. 1993;88:334-8.

Scientific Papers

Prediction/ Diagnosis /Treatment of Health Problems with Amino Acids: